✦ LIBER ✦

The hepatitis C self-management programme: a randomized controlled trial

✍ Scribed by E. J. Groessl; K. R. Weingart; C. J. Stepnowsky; A. L. Gifford; S. M. Asch; S. B. Ho

Book ID: 108886473
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 372 KB
Volume: 18
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2010.01328.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized controlled trial of a lay-fac

Randomized controlled trial of a lay-facilitated angina management programme

✍ Gill Furze; Helen Cox; Veronica Morton; Ling-Hsiang Chuang; Robert J.P. Lewin; P 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

Nurse-led self-management group programm

Nurse-led self-management group programme for patients with congestive heart failure: randomized controlled trial

✍ Esther S.T.F. Smeulders; Jolanda C.M. Van Haastregt; Ton Ambergen; Nicole H.K.M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Interferon-α in acute posttransfusion he

Interferon-α in acute posttransfusion hepatitis C:. A randomized, controlled trial

✍ Lluis Viladomiu; Dr. Joan Genescà; Juan I. Esteban; Helena Allende; Antonio Gonz 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

Effects of a self-management arthritis p

Effects of a self-management arthritis programme with an added exercise component for osteoarthritic knee: randomized controlled trial

✍ Y. B. Yip; Janet W. H. Sit; Karin K. Y. Fung; Doris Y. S. Wong; Samantha Y. C. C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

Short-term interferon-alfa therapy for a

Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial

✍ Hideyuki Nomura; Suketo Sou; Hironori Tanimoto; Takashi Nagahama; Yoichi Kimura; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

Individualized treatment duration for he

Individualized treatment duration for hepatitis C genotype 1 patients: A randomized controlled trial

✍ Alessandra Mangia; Nicola Minerva; Donato Bacca; Raffaele Cozzolongo; Giovanni L 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB 👁 2 views

It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as effective as standard 48-week treatment. Patients (n = 696) received peginterferon alfa-2a, 180 mg/week, or peginterferon alfa-2b, 1.5 mg/kg/week, p